NEW DELHI and MUMBAI, India, May 20, 2025 /PRNewswire/ -- Global pharma major Lupin Limited (Lupin) announced today its plan to use Honeywell's Solstice® Air (HFO-1234ze cGMP) propellant to transform ...
– Lupin’s R&D teams are working on products with a near-zero global warming potential propellant FRANKFURT, Germany, Oct. 28, 2024 /PRNewswire/ — Global pharma major Lupin Limited (Lupin) today ...
Global pharma major Lupin has firmed up its plan to use Honeywell’s Solstice Air (HFO-1234ze(E) cGMP) propellant to transform respiratory care through the development of next-generation inhalers.
Lupin is now utilizing Honeywell’s Solstice Air in its respiratory inhalers, significantly improving respiratory care with propellants that have near-zero global warming potential. This advancement, ...
Lupin is set to become first Indian company to fully integrate Honeywell's Solstice® Air in its respiratory inhalers at scale, redefining respiratory care with near-zero global warming potential ...
Lupin is set to become first Indian company to fully integrate Honeywell's Solstice® Air in its respiratory inhalers at scale, redefining respiratory care with near-zero global warming potential ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results